Excess EDRF/NO, a potentially deleterious condition that may be involved in accelerated atherogenesis and other chronic disease states
- 1 July 1995
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 26 (4) , 667-680
- https://doi.org/10.1016/0306-3623(94)00222-9
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shockPublished by Elsevier ,2005
- The role of nitric oxide and cGMP in platelet adhesion to vascular endotheliumPublished by Elsevier ,2005
- Evidence for a Role of Nitric Oxide in Hypovolemic Hemorrhagic ShockJournal of Cardiovascular Pharmacology, 1992
- Coronary atherosclerosis: Current therapeutic approaches and future trendsLife Sciences, 1991
- The Cardiovascular Response of Normal Humans to the Administration of EndotoxinNew England Journal of Medicine, 1989
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Inhibitory effect of α-tocopherol on the formation of nitrosomorpholine in mice treated with morpholine and exposed to nitrogen dioxideCarcinogenesis: Integrative Cancer Research, 1986
- Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)New England Journal of Medicine, 1983
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Activation of cerebral guanylate cyclase by nitric oxideBiochemical and Biophysical Research Communications, 1977